Mammalian cell components (N/A)

Mammalian cell components refers to the collective structural and functional elements of cells derived from mammals, including organelles like mitochondria and the nucleus, as well as the plasma membrane and cytoskeleton (ChEMBL, 2024). In the context of drug discovery, this term is typically used as a high-level classification for biological assays where the specific molecular target is either unknown or involves the coordinated action of multiple cellular structures (PubChem, 2024). For instance, many early-stage phenotypic screens or studies involving general cytotoxic agents are mapped to this category because the observed effect is a result of global cellular disruption rather than binding to a single protein (NCBI, 2023). Because it encompasses thousands of distinct molecules and pathways, it does not meet the criteria for a specific therapeutic target in modern drug development. Consequently, it is often flagged in bioinformatic pipelines as a generic or incorrect target designation that requires further refinement to identify a precise mechanism of action. Drugs associated with this classification often include general anesthetics or detergents that alter membrane fluidity or integrity (StatPearls, 2023). This broad categorization is useful for initial data organization but lacks the specificity required for structure-based drug design. Overall, it serves as a placeholder for complex biological systems in pharmacological databases.

Other names

Cellular componentsMammalian cellsHost cell componentsCell-component

Non-specific disruption of cellular structures, alteration of membrane fluidity, or general interference with metabolic pathways (NCBI, 2023).